|
Volumn 17, Issue 6, 1996, Pages 509-525
|
Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative
a b a b b c d e |
Author keywords
clinical trials; data and safety monitoring; disease prevention; multiple endpoints; stopping rules
|
Indexed keywords
CALCIUM;
ERGOCALCIFEROL;
ESTROGEN;
GESTAGEN;
ARTICLE;
BREAST CANCER;
CLINICAL TRIAL;
COLORECTAL CANCER;
FEMALE;
HORMONE SUBSTITUTION;
HUMAN;
MORBIDITY;
MORTALITY;
PATIENT MONITORING;
BAYES THEOREM;
COMPARATIVE STUDY;
DECISION SUPPORT SYSTEM;
HEALTH SURVEY;
INCIDENCE;
INTERVENTION STUDY;
MEDICAL ETHICS;
METHODOLOGY;
SAFETY;
STANDARD;
STATISTICAL ANALYSIS;
WOMEN'S HEALTH;
BAYES THEOREM;
CLINICAL TRIALS;
DATA INTERPRETATION, STATISTICAL;
DECISION SUPPORT TECHNIQUES;
ETHICS, MEDICAL;
FEMALE;
HEALTH STATUS INDICATORS;
HUMANS;
INCIDENCE;
INTERVENTION STUDIES;
MORTALITY;
SAFETY;
WOMEN'S HEALTH;
|
EID: 0030339908
PISSN: 01972456
EISSN: None
Source Type: Journal
DOI: 10.1016/S0197-2456(96)00016-5 Document Type: Article |
Times cited : (69)
|
References (9)
|